Correction to: Targeted Anti-IL-5 Therapies and Future Therapeutics for Hypereosinophilic Syndrome and Rare Eosinophilic Conditions

被引：0
|
作者：
Aasha Harish
Stanley A. Schwartz
机构：
[1] University at Buffalo,Division of Allergy and Immunology, Department of Medicine, Jacobs School of Medicine and Biomedical Sciences
来源：
Clinical Reviews in Allergy & Immunology | 2020年 / 59卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The original version of this article unfortunately contained a mistake in the fifth paragraph of the “Conclusion” section.
引用
收藏
页码：273 / 273
相关论文
共 50 条
  • [21] Anti-IL-5 only partially effective in eosinophilic esophagitis.
    Fellermann, Klaus
    MEDIZINISCHE KLINIK, 2010, 105 (06) : 441 - 441
  • [22] The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: Asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis
    Nagase, Hiroyuki
    Ueki, Shigeharu
    Fujieda, Shigeharu
    ALLERGOLOGY INTERNATIONAL, 2020, 69 (02) : 178 - 186
  • [23] Targeting the IL-5 pathway in eosinophilic asthma: A comparison of anti-IL-5 versus anti-IL-5 receptor agents (vol 79, pg 2943, 2024)
    Jackson, D. J.
    Wechsler, M. E.
    Brusselle, G.
    Buhl, R.
    ALLERGY, 2025,
  • [24] Mepolizumab. Humanized anti-IL-5 monoclonal antibody, Treatment of hypereosinophilic syndromes
    Revill, P.
    Mealy, N.
    DRUGS OF THE FUTURE, 2007, 32 (10) : 868 - 873
  • [25] Anti-IL-5 treatments in severe eosinophilic asthma: real life datas
    Ozdel Ozturk, Betul
    Bavbek, Sevim
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2020, 68 (02): : 148 - 159
  • [26] The Effect of Anti-IL-5 Therapy on Esophageal Mastocytosis in Pediatric Eosinophilic Esophagitis
    Otani, I. M.
    Bhagat, M.
    Newbury, R. O.
    Dohil, R.
    Broide, D. H.
    Aceves, S. S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB202 - AB202
  • [27] Anti-IL-5 Biologicals Targeting Severe Late Onset Eosinophilic Asthma
    Ozyigit, Leyla Pur
    Ozturk, Ayse Bilge
    Bavhek, Sevim
    TURKISH THORACIC JOURNAL, 2020, 21 (01): : 61 - 68
  • [28] Mepolizumab (anti-IL-5) reduces exacerbations in patients with refractory eosinophilic asthma
    Pavord, Ian
    Korn, Stephanie
    Howarth, Peter
    Bleecker, Eugene
    Buhl, Roland
    Keene, Oliver
    Ortega, Hector
    Pascal, Pascal Chanez
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [29] Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases
    Menzella, Francesco
    Lusuardi, Mirco
    Galeone, Carla
    Taddei, Sofia
    Zucchi, Luigi
    JOURNAL OF ASTHMA AND ALLERGY, 2015, 8 : 105 - 114
  • [30] Remission of refractory eosinophilic gastrointestinal disease in an eosinophilic granulomatosis with polyangiitis patient by anti-IL-5 therapy
    Wang, Chrong-Reen
    Tsai, Hung-Wen
    Wu, I-Chin
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2023, 122 (12) : 1345 - 1346
12345